Literature DB >> 29570783

Defining the role of NK cells during dengue virus infection.

Anuja Mathew1.   

Abstract

In recent years, our understanding of the complex number of signals that need to be integrated between a diverse number of receptors present on natural killer (NK) cells and ligands present on target cells has improved. Here, we review the progress made in identifying interactions between dengue viral peptides presented on HLA Class 1 molecules with inhibitory and activating killer-like immunoglobulin receptors on NK cells, direct interactions of viral proteins with NK cell receptors, the involvement of dengue virus-specific antibodies in mediating antibody-dependent cell-mediated cytotoxicity and the role of soluble factors in modulating NK cell responses. We discuss findings of NK cell activation early after natural dengue infection, and point to the role that NK cells may play in regulating both innate and adaptive immune responses, in the context of our new appreciation of interactions of dengue virus with specific NK cell receptors. With a number of flavivirus vaccine candidates in clinical trials, how NK cells respond to attenuated dengue virus and subunit protein vaccine candidates and shape adaptive immunity will need to be considered.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  NK cell; activation; cytokines; innate lymphoid cells; killer cell immunoglobulin-like receptors

Year:  2018        PMID: 29570783      PMCID: PMC6050221          DOI: 10.1111/imm.12928

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  43 in total

1.  NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.

Authors:  Andreas Glässner; Marianne Eisenhardt; Benjamin Krämer; Christian Körner; Martin Coenen; Tilman Sauerbruch; Ulrich Spengler; Jacob Nattermann
Journal:  Lab Invest       Date:  2012-03-26       Impact factor: 5.662

2.  Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules.

Authors:  Lena Fadda; Geraldine M O'Connor; Swati Kumar; Alicja Piechocka-Trocha; Clair M Gardiner; Mary Carrington; Daniel W McVicar; Marcus Altfeld
Journal:  J Virol       Date:  2011-04-06       Impact factor: 5.103

3.  TRAIL is a novel antiviral protein against dengue virus.

Authors:  Rajas V Warke; Katherine J Martin; Kris Giaya; Sunil K Shaw; Alan L Rothman; Irene Bosch
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

4.  Influence of KIR genes and their HLA ligands in susceptibility to dengue in a population from southern Brazil.

Authors:  L M Beltrame; A M Sell; R A Moliterno; S L Clementino; D M Cardozo; M M Dalalio; U J Fonzar; J E Visentainer
Journal:  Tissue Antigens       Date:  2013-12

5.  Differences in activation and tissue homing markers of natural killer cell subsets during acute dengue infection.

Authors:  Rassamon Keawvichit; Ladawan Khowawisetsut; Sakaorat Lertjuthaporn; Kanchana Tangnararatchakit; Nopporn Apiwattanakul; Sutee Yoksan; Ampaiwan Chuansumrit; Kulkanya Chokephaibulkit; Aftab A Ansari; Nattawat Onlamoon; Kovit Pattanapanyasat
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

6.  Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity.

Authors:  I Kurane; D Hebblewaite; W E Brandt; F A Ennis
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

7.  Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1.

Authors:  Chiea Chuen Khor; Tran Nguyen Bich Chau; Junxiong Pang; Sonia Davila; Hoang Truong Long; Rick T H Ong; Sarah J Dunstan; Bridget Wills; Jeremy Farrar; Ta Van Tram; Tran Thi Gan; Nguyen Thi Nguyet Binh; Le Trung Tri; Le Bich Lien; Nguyen Minh Tuan; Nguyen Thi Hong Tham; Mai Ngoc Lanh; Nguyen Minh Nguyet; Nguyen Trong Hieu; Nguyen Van N Vinh Chau; Tran Thi Thuy; Dennis E K Tan; Anavaj Sakuntabhai; Yik-Ying Teo; Martin L Hibberd; Cameron P Simmons
Journal:  Nat Genet       Date:  2011-10-16       Impact factor: 38.330

8.  Circulating levels of soluble MICB in infants with symptomatic primary dengue virus infections.

Authors:  Daniel H Libraty; Lei Zhang; AnaMae Obcena; Job D Brion; Rosario Z Capeding
Journal:  PLoS One       Date:  2014-05-28       Impact factor: 3.240

9.  Interaction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cells.

Authors:  E Townsley; G O'Connor; C Cosgrove; M Woda; M Co; S J Thomas; S Kalayanarooj; I-K Yoon; A Nisalak; A Srikiatkhachorn; S Green; H A F Stephens; E Gostick; D A Price; M Carrington; G Alter; D W McVicar; A L Rothman; A Mathew
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

10.  Dengue virus activates membrane TRAIL relocalization and IFN-α production by human plasmacytoid dendritic cells in vitro and in vivo.

Authors:  Mariana Gandini; Christophe Gras; Elzinandes Leal Azeredo; Luzia Maria de Oliveira Pinto; Nikaïa Smith; Philippe Despres; Rivaldo Venâncio da Cunha; Luiz José de Souza; Claire Fernandes Kubelka; Jean-Philippe Herbeuval
Journal:  PLoS Negl Trop Dis       Date:  2013-06-06
View more
  6 in total

1.  Natural killer cell transcriptional control, subsets, receptors and effector function.

Authors:  Daniel M Altmann
Journal:  Immunology       Date:  2019-02       Impact factor: 7.397

2.  Major Histocompatibility Complex Class I Chain-Related A and B (MICA and MICB) Gene, Allele, and Haplotype Associations With Dengue Infections in Ethnic Thais.

Authors:  Panpimon Luangtrakool; Sasijit Vejbaesya; Komon Luangtrakool; Somporn Ngamhawornwong; Kusuma Apisawes; Siripen Kalayanarooj; Louis R Macareo; Stefan Fernandez; Richard G Jarman; Robert W M Collins; Steven T Cox; Anon Srikiatkhachorn; Alan L Rothman; Henry A F Stephens
Journal:  J Infect Dis       Date:  2020-08-04       Impact factor: 5.226

3.  HLA Upregulation During Dengue Virus Infection Suppresses the Natural Killer Cell Response.

Authors:  Julia L McKechnie; Davis Beltrán; Arcelys Pitti; Lisseth Saenz; Ana B Araúz; Rosemary Vergara; Eva Harris; Lewis L Lanier; Catherine A Blish; Sandra López-Vergès
Journal:  Front Cell Infect Microbiol       Date:  2019-07-23       Impact factor: 5.293

Review 4.  Research advance of natural products in tumor immunotherapy.

Authors:  Jin-Ling Huo; Wen-Jia Fu; Zheng-Han Liu; Nan Lu; Xiang-Qian Jia; Zhang-Suo Liu
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

Review 5.  Natural killer cells in antiviral immunity.

Authors:  Niklas K Björkström; Benedikt Strunz; Hans-Gustaf Ljunggren
Journal:  Nat Rev Immunol       Date:  2021-06-11       Impact factor: 53.106

Review 6.  Natural killer cell responses to emerging viruses of zoonotic origin.

Authors:  Carlos Diaz-Salazar; Joseph C Sun
Journal:  Curr Opin Virol       Date:  2020-08-09       Impact factor: 7.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.